tradingkey.logo

Prophase Labs Inc

PRPH
View Detailed Chart
0.363USD
0.0000.00%
Close 02/06, 16:00ETQuotes delayed by 15 min
1.51MMarket Cap
LossP/E TTM

Prophase Labs Inc

0.363
0.0000.00%
Intraday
1m
30m
1h
D
W
M
D

Today

0.00%

5 Days

0.00%

1 Month

0.00%

6 Months

+14.57%

Year to Date

-18.97%

1 Year

+39.52%

View Detailed Chart

TradingKey Stock Score of Prophase Labs Inc

Currency: USD Updated: 2026-01-02

Key Insights

Prophase Labs Inc's fundamentals are relatively weak, and its growth potential is good.Its valuation is considered fairly valued, ranking 67 out of 78 in the Healthcare Providers & Services industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as , with the highest price target at 16.00.In the medium term, the stock price is expected to trend down.Despite a strong stock market performance over the past month, the company shows weak fundamentals and technicals, which don't support the current strong trend.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Prophase Labs Inc's Score

Industry at a Glance

Industry Ranking
67 / 78
Overall Ranking
479 / 4550
Industry
Healthcare Providers & Services

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Neutral

Prophase Labs Inc Highlights

StrengthsRisks
ProPhase Labs, Inc. is a biotech, genomics, and consumer products company. The Company is engaged in providing whole genome sequencing solutions, diagnostic development, such as its potentially life-saving test for the early detection of esophageal cancer and a direct-to-consumer marketing platform for OTC dietary supplements. It develops, manufactures, and commercializes health and wellness solutions. Its Diagnostic services segment provides diagnostic information services to a range of customers in the United States, including health plans, third-party payers and government organizations. Its Consumer products segment is engaged in the research, development, manufacture, distribution, marketing and sale of OTC consumer healthcare products and dietary supplements in the United States and provides personal genomics products and services. The Company also develops and markets dietary supplements under the TK Supplement brand, which includes Legendz XL and Triple Edge XL.
Growing
The company is in a growing phase, with the latest annual income totaling USD 6.77M.
Overvalued
The company’s latest PE is -0.02, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 303.07K shares, decreasing 50.33% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 53.19K shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 4.02.

Analyst Rating

Based on 0 analysts
--
Current Rating
16.000
Target Price
+5111.73%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Prophase Labs Inc News

More news coming soon, stay tuned...

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Prophase Labs Inc Info

ProPhase Labs, Inc. is a biotech, genomics, and consumer products company. The Company is engaged in providing whole genome sequencing solutions, diagnostic development, such as its potentially life-saving test for the early detection of esophageal cancer and a direct-to-consumer marketing platform for OTC dietary supplements. It develops, manufactures, and commercializes health and wellness solutions. Its Diagnostic services segment provides diagnostic information services to a range of customers in the United States, including health plans, third-party payers and government organizations. Its Consumer products segment is engaged in the research, development, manufacture, distribution, marketing and sale of OTC consumer healthcare products and dietary supplements in the United States and provides personal genomics products and services. The Company also develops and markets dietary supplements under the TK Supplement brand, which includes Legendz XL and Triple Edge XL.
Ticker SymbolPRPH
CompanyProphase Labs Inc
CEOKarkus (Ted William)
Websitehttps://www.prophaselabs.com/
KeyAI